Lv51
1272 积分 2021-01-04 加入
The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta‐analysis
58分钟前
已完结
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
8个月前
已完结
PIK3CA mutations in vascular malformations
1年前
已完结
Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing
1年前
已完结
Vascular Anomalies: Diagnosis of Complicated Anomalies and New Medical Treatment Options
1年前
已完结
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Non-Squamous EGFR-Wildtype NSCLC in the Phase 2 LUMINOSITY Trial
1年前
已完结
Litifilimab (BIIB059), a promising investigational drug for cutaneous lupus erythematosus
1年前
已完结
Hepatocellular Carcinoma
1年前
已完结
MET alterations in advanced non-small cell lung cancer
2年前
已完结
MET alterations in NSCLC—Current Perspectives and Future Challenges
2年前
已完结
皖公网安备34019202002308
